Literature DB >> 12547604

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity.

Anke Huckriede1, Laura Bungener, Wouter ter Veer, Marijke Holtrop, Toos Daemen, Abraham M Palache, Jan Wilschut.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12547604     DOI： 10.1016/s0264-410x(02)00542-x

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  10 in total

Review 1.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

2.  Conference report--adjuvants and delivery: improving on vaccine immunogenicity highlights from the viral vaccine meeting; October 25-28, 2003; Barcelona, Spain.

Authors:  Elena Armandola
Journal:  MedGenMed       Date:  2004-01-26

3.  Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.

Authors:  A Holvast; A Huckriede; J Wilschut; G Horst; J J C De Vries; C A Benne; C G M Kallenberg; M Bijl
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

4.  Immunogenicity and protective efficacy of virosome based vaccines against Newcastle disease.

Authors:  Rajinder Singh; Prem C Verma; Satparkash Singh
Journal:  Trop Anim Health Prod       Date:  2009-09-02       Impact factor: 1.559

5.  A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila.

Authors:  Graeme J M Cowan; Ulrike Bockau; Janna Eleni-Muus; Ingo Aldag; Kay Samuel; Alison M Creasey; Marcus W W Hartmann; David R Cavanagh
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

6.  A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro.

Authors:  Gabriela Tapia-Calle; Philip A Born; Georgia Koutsoumpli; Martin Ignacio Gonzalez-Rodriguez; Wouter L J Hinrichs; Anke L W Huckriede
Journal:  Vaccines (Basel)       Date:  2019-11-13

Review 7.  Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review.

Authors:  Khatereh Asadi; Ahmad Gholami
Journal:  Int J Biol Macromol       Date:  2021-04-16       Impact factor: 6.953

8.  Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity.

Authors:  Varun Kumar; Ramesh Kumar; V K Jain; Suman Nagpal
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

9.  A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

Authors:  Shinji L Okitsu; Olivier Silvie; Nicole Westerfeld; Marija Curcic; Andreas R Kammer; Markus S Mueller; Robert W Sauerwein; John A Robinson; Blaise Genton; Dominique Mazier; Rinaldo Zurbriggen; Gerd Pluschke
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

10.  Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.

Authors:  Christophe Barnier-Quer; Abdelrahman Elsharkawy; Stefan Romeijn; Alexander Kros; Wim Jiskoot
Journal:  Pharmaceutics       Date:  2013-07-25       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.